Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprazygomatic maxillary nerve block after cleft palate surgery in children
2018-001457-28Phase 3
- Sponsor
- CHU Amiens-Picardie
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of levobupivacaine in cleft palate (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Postoperative morphine consumption over 48 hours.
02
Drugs
levobupivacaine
03
Conditions
cleft palate
Beyond the preview
Go deeper on 2018-001457-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001457-28.